Importantly, CPT (a STAT3 inhibitor) markedly decreased the lung metastatic nodules induced by knockdown of BECN1, suggesting that pharmacological inhibition of STAT3 is a promising method for advanced CRC patients with metastasis. This evidence concerns the gene BECN1 and colorectal carcinoma.